CytoDyn Presenting Update on its Therapeutic Antibody Programs at the Therapeutic Potential of Antibodies for HIV Meeting in Boston, MA

LUTZ, Fla.--(BUSINESS WIRE)--CytoDyn Inc. (the "Company")(OTC QB:CYDY), a biotechnology company focused on the development of new therapies for combating infection with immune deficiency virus and other antibody applications, announced today that it is presenting an update on its Human Immunodeficiency Virus ("HIV") and Feline Immunodeficiency Virus ("FIV") therapeutic antibody programs, including new preclinical findings, at the Therapeutic Potential of Antibodies for HIV meeting sponsored by Search For A Cure, Inc. in Boston, Massachusetts.